Classer les publications sur l'année

  • Pharmaco-EpidĂ©miologie

    Air, pollution et cancer : baromĂštre de pollutions en France

    NEROME S, QUOIX E, DUBURCQ A

    Carnet de routes-Editions Bash ; 1-17

  • Pharmaco-EpidĂ©miologie

    A survey on the prevalence of orofacial herpes in France : The INSTANT Study

    LORETTE G, CROCHARD A, MIMAUD V, WOLKENSTEIN P, STALDER JF, EL HASNAOUI A

    J Am Acad Dermatol ; 55(2):225-232

  • Pharmaco-EpidĂ©miologie

    Venous thromboembolism and mortality after hip fracture surgery : The ESCORTE Study

    ROSENCHER N, VIELPEAU C, EMMERICH J, FAGNANI F, SAMAMA  CM, The ESCORTE Group

    J Thromb Haemost ; 3(9):2006-2014

  • Pharmaco-EpidĂ©miologie

    Results from the observational study EPIGRAM : management of excess weight in general practice and follow-up of patients treatd with orlistat

    VRAY M, JOUBERT JM, ESCHWEGE E, LIARD F, FAGNANI F, MONTESTRUC F, FAGES S, BEGAUD B

    Thérapie ; 60(1):153-162

  • Pharmaco-EpidĂ©miologie

    Prise en charge de la douleur en mĂ©decine gĂ©nĂ©rale : l’Ă©tude EPIDOL

    EMERY C, GEORGE B, GOMAS JM, DELFIEU D, MIMAUD V, GUILLON P, FAGNANI F

    Douleurs ; 6(6):366-373

  • Pharmaco-EpidĂ©miologie

    Prévalence de la bronchopneumopathie chronique obstructive (BPCO) : estimation pour la France

    BENARD E, DETOURNAY B, NEUKIRCH F, PRIBIL C, EL HASNAOUI A

    La Lettre du Pneumologue ; 8(4):158-163

  • Pharmaco-EpidĂ©miologie

    Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community : a nationwide survey

    BREZIN AP, LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G

    Arch Ophtalmol ; 123(8):1117-1124

  • Pharmaco-EpidĂ©miologie

    Prevalence and burden of self-reported blindness and low vision for individuals living in institutions : a nationwide survey

    BREZIN AP, LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G

    Health and Quality of Life Outcomes ; 3(27)

  • Pharmaco-EpidĂ©miologie

    Incidence of Herpes Simplex Virus Keratitis In France

    LABETOULLE M, AUQUIER P, CONRAD H, CROCHARD A, DANILOSKI M, BOUEE S, EL HASNAOUI A, COLIN J

    Ophtalmology ; 112(5):888-895

  • Pharmaco-EpidĂ©miologie

    Identification des freins au dĂ©pistage et Ă  la prise en charge des patients infectĂ©s par le virus de l’hĂ©patite C : Etude Gymkhana 1, France, 9 au 12 dĂ©cembre 2002

    BENTATA M, AUBERT JP, BOUEE S, COMPAGNON M, ELGHOZI B, LIVROZET JM, MECHALI D, PERDRIEAU F, PY AM, ROZEMBAUM W, TAULERA O, WAJSBROT A

    BEH ; 43:215-216

  • Pharmaco-EpidĂ©miologie

    Epidemiology of restless legs syndrome in French adults A nationwide survey: The INSTANT Study

    TISON F, CROCHARD A, LEGER D, BOUEE S, LAINEY E, EL HASNAOUI A

    Neurology ; 65:239-246

  • Pharmaco-EpidĂ©miologie

    Epidemiology and costs of diabetes treated with insulin in France

    DETOURNAY B, RACCAH D, CADILHAC M, ESCHWEGE E

    Diabetes Metab ; 31(2):S1-S18

  • Pharmaco-EpidĂ©miologie

    Epidémiologie de la maladie thromboembolique veineuse

    BENARD E, LAFUMA A, RAVAUD P

    Presse Med ; 2005;34(6):415-419

  • Pharmaco-EpidĂ©miologie

    Effects of dyskinesias in Parkinson’s disease on quality of life and health-related costs : a prospective European study

    PECHEVIS C, CLARKE E, VIEREGGE P, KHOSHNOOD B, DESCHASEAUX-VOINET C, BERDEAUX G, ZIEGLER M

    Eur J Neurol ; 12:956-963

  • Pharmaco-EpidĂ©miologie

    DĂ©pistage de l’infection parle VHC en mĂ©decine gĂ©nĂ©rale

    AUBERT JP, BOUEE S, BENTATA M, COMPAGNON M, ELGHOZI B, LIVROZET JM, MECHALI D, PERDRIEAU F, PY AM, ROZEMBAUM W, TAULERA O, WAJSBROT A

    La Revue du Praticien ; 19:895-899